Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

611 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Progressive histoplasmosis with hemophagocytic lymphohistiocytosis and epithelioid cell granulomatosis: A case report and review of the literature.
Schulze AB, Heptner B, Kessler T, Baumgarten B, Stoica V, Mohr M, Wiewrodt R, Warneke VS, Hartmann W, Wüllenweber J, Schülke C, Schäfers M, Wilmes D, Becker K, Schmidt LH, Groll AH, Berdel WE. Schulze AB, et al. Among authors: hartmann w. Eur J Haematol. 2017 Jul;99(1):91-100. doi: 10.1111/ejh.12886. Epub 2017 May 11. Eur J Haematol. 2017. PMID: 28349614 Review.
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups.
Schmidt LH, Kümmel A, Görlich D, Mohr M, Bröckling S, Mikesch JH, Grünewald I, Marra A, Schultheis AM, Wardelmann E, Müller-Tidow C, Spieker T, Schliemann C, Berdel WE, Wiewrodt R, Hartmann W. Schmidt LH, et al. Among authors: hartmann w. PLoS One. 2015 Aug 27;10(8):e0136023. doi: 10.1371/journal.pone.0136023. eCollection 2015. PLoS One. 2015. PMID: 26313362 Free PMC article.
Blood group antigen A type 3 expression is a favorable prognostic factor in advanced NSCLC.
Schmidt LH, Kuemmel A, Schliemann C, Schulze A, Humberg J, Mohr M, Görlich D, Hartmann W, Bröckling S, Marra A, Hillejan L, Goletz S, Karsten U, Berdel WE, Spieker T, Wiewrodt R. Schmidt LH, et al. Among authors: hartmann w. Lung Cancer. 2016 Feb;92:8-14. doi: 10.1016/j.lungcan.2015.11.019. Epub 2015 Nov 27. Lung Cancer. 2016. PMID: 26775589
Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction.
Stucke-Ring J, Ronnacker J, Brand C, Höltke C, Schliemann C, Kessler T, Schmidt LH, Harrach S, Mantke V, Hintelmann H, Hartmann W, Wardelmann E, Lenz G, Wünsch B, Müller-Tidow C, Mesters RM, Schwöppe C, Berdel WE. Stucke-Ring J, et al. Among authors: hartmann w. Oncotarget. 2016 Dec 13;7(50):82458-82472. doi: 10.18632/oncotarget.12559. Oncotarget. 2016. PMID: 27738341 Free PMC article.
PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation.
Albring JC, Inselmann S, Sauer T, Schliemann C, Altvater B, Kailayangiri S, Rössig C, Hartmann W, Knorrenschild JR, Sohlbach K, Groth C, Lohoff M, Neubauer A, Berdel WE, Burchert A, Stelljes M. Albring JC, et al. Among authors: hartmann w. Bone Marrow Transplant. 2017 Feb;52(2):317-320. doi: 10.1038/bmt.2016.274. Epub 2016 Nov 28. Bone Marrow Transplant. 2017. PMID: 27892950 Clinical Trial. No abstract available.
Potential therapeutic impact of CD13 expression in non-small cell lung cancer.
Schmidt LH, Brand C, Stucke-Ring J, Schliemann C, Kessler T, Harrach S, Mohr M, Görlich D, Marra A, Hillejan L, Müller-Tidow C, Lenz G, Wardelmann E, Wiewrodt R, Berdel WE, Schwöppe C, Hartmann W. Schmidt LH, et al. Among authors: hartmann w. PLoS One. 2017 Jun 12;12(6):e0177146. doi: 10.1371/journal.pone.0177146. eCollection 2017. PLoS One. 2017. PMID: 28604784 Free PMC article.
611 results